ZIDOVUDINE

ZIDOVUDINE was reported 10369 times

ZIDOVUDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PINEALOBLASTOMA 79 0.8495
1 BLOOD PYRUVIC ACID DECREASED 17 0.8095
2 CONGENITAL NEOPLASM 21 0.7778
3 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 100 0.7752
4 AIDS CHOLANGIOPATHY 8 0.6667
5 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 168 0.6043
6 ULTRASOUND ANTENATAL SCREEN 51 0.5312
7 CLOACAL EXSTROPHY 31 0.5254
8 LACTATE PYRUVATE RATIO INCREASED 24 0.5217
9 CONGENITAL HIV INFECTION 20 0.5128
10 RETROPERITONEAL DISORDER 10 0.4348
11 BLADDER AGENESIS 32 0.4324
12 CSF HIV ESCAPE SYNDROME 55 0.3986
13 PERITONEAL THICKENING 10 0.3571
14 CSF HIV VIRUS IDENTIFIED 8 0.3478
15 BLOOD PYRUVIC ACID INCREASED 16 0.3404
16 MITOCHONDRIAL TOXICITY 241 0.2935
17 GASTROINTESTINAL DISORDER CONGENITAL 28 0.2642
18 AIDS ENCEPHALOPATHY 15 0.2586
19 GENITALIA EXTERNAL AMBIGUOUS 44 0.2543
20 HIV WASTING SYNDROME 9 0.2500
21 MECONIUM STAIN 37 0.2403
22 IMMUNE RECONSTITUTION SYNDROME 304 0.2355
23 ASTROCYTOMA MALIGNANT 24 0.2330
24 VERTICAL INFECTION TRANSMISSION 26 0.2301
25 CONGENITAL ECTOPIC BLADDER 11 0.2292
26 NEUTROPENIA NEONATAL 51 0.2277
27 CONGENITAL CYTOMEGALOVIRUS INFECTION 37 0.2176
28 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 23 0.2072
29 LIPODYSTROPHY ACQUIRED 436 0.2052
30 TUBERCULOID LEPROSY 13 0.2000
31 CAUDAL REGRESSION SYNDROME 30 0.1923
32 ALPHA 1 FOETOPROTEIN ABNORMAL 18 0.1800
33 CONGENITAL NAEVUS 25 0.1761
34 HIV VIRAEMIA 36 0.1714
35 CONGENITAL TOXOPLASMOSIS 9 0.1667
36 AIDS DEMENTIA COMPLEX 10 0.1639
37 ANAEMIA NEONATAL 77 0.1598
38 CONGENITAL GENITAL MALFORMATION 25 0.1562
39 VIRAL MUTATION IDENTIFIED 568 0.1541
40 AIDS RELATED COMPLICATION 10 0.1538
41 VIROLOGIC FAILURE 816 0.1516
42 CONGENITAL TERATOMA 13 0.1512
43 TETHERED CORD SYNDROME 31 0.1403
44 TRISOMY 18 52 0.1365
45 CONGENITAL PULMONARY VALVE DISORDER 13 0.1262
46 OPTIC NERVE NEOPLASM 11 0.1170
47 CONGENITAL MUSCULOSKELETAL DISORDER 10 0.1149
48 GASTROINTESTINAL MALFORMATION 24 0.1148
49 RETINOBLASTOMA 12 0.1101
50 MITOCHONDRIAL MYOPATHY 24 0.1101
51 BLOOD ANTIDIURETIC HORMONE INCREASED 10 0.1075
52 PLAGIOCEPHALY 53 0.1062
53 CONGENITAL ANOMALY IN OFFSPRING 14 0.1061
54 MENINGOMYELOCELE 63 0.1050
55 HYDROPS FOETALIS 63 0.1028
56 THYMUS ENLARGEMENT 16 0.1000
57 SUDDEN INFANT DEATH SYNDROME 49 0.0996
58 CHORDEE 14 0.0993
59 NECROTISING ENTEROCOLITIS NEONATAL 40 0.0985
60 HIV INFECTION 293 0.0971
61 MATERNAL CONDITION AFFECTING FOETUS 21 0.0950
62 FOETAL ALCOHOL SYNDROME 9 0.0900
63 FOETAL EXPOSURE DURING DELIVERY 59 0.0870
64 LIPOATROPHY 82 0.0861
65 CONGENITAL MITRAL VALVE INCOMPETENCE 12 0.0857
66 DEXTROCARDIA 16 0.0851
67 NEONATAL HYPONATRAEMIA 10 0.0820
68 ULTRASOUND ANTENATAL SCREEN ABNORMAL 18 0.0818
69 ERGOT POISONING 10 0.0800
70 CONGENITAL HEART VALVE DISORDER 19 0.0798
71 NEONATAL RESPIRATORY ARREST 11 0.0753
72 BLOOD KETONE BODY PRESENT 14 0.0749
73 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 17 0.0730
74 ANAL ATRESIA 38 0.0712
75 EXOMPHALOS 38 0.0708
76 MITOCHONDRIAL CYTOPATHY 31 0.0705
77 BLOOD HIV RNA INCREASED 127 0.0700
78 BONE DEMINERALISATION 74 0.0699
79 KAPOSI'S SARCOMA 35 0.0697
80 UMBILICAL CORD ABNORMALITY 36 0.0683
81 NEONATAL DISORDER 107 0.0675
82 ENLARGED CLITORIS 11 0.0667
83 PATHOGEN RESISTANCE 599 0.0657
84 ASTROCYTOMA, LOW GRADE 11 0.0647
85 CD4 LYMPHOCYTES INCREASED 15 0.0644
86 DIARRHOEA NEONATAL 8 0.0630
87 NODULAR REGENERATIVE HYPERPLASIA 39 0.0607
88 VENTRICULAR HYPOPLASIA 15 0.0600
89 CONGENITAL TRICUSPID VALVE ATRESIA 9 0.0600
90 RHABDOMYOSARCOMA 11 0.0585
91 NEURAL TUBE DEFECT 42 0.0578
92 POLYDACTYLY 66 0.0569
93 DIASTASIS RECTI ABDOMINIS 9 0.0559
94 MACROCEPHALY 21 0.0541
95 TRISOMY 21 68 0.0540
96 RICKETS 10 0.0529
97 DYSDIADOCHOKINESIS 9 0.0526
98 BLOOD LACTIC ACID INCREASED 276 0.0523
99 FACIAL WASTING 14 0.0520
100 SPINE MALFORMATION 18 0.0519
101 SEPSIS NEONATAL 41 0.0505
102 ACQUIRED IMMUNODEFICIENCY SYNDROME 26 0.0501
103 ANAEMIA MACROCYTIC 107 0.0501
104 GRAFT DYSFUNCTION 14 0.0491
105 NEONATAL ASPIRATION 16 0.0488
106 THROMBOCYTHAEMIA 27 0.0486
107 FOETAL GROWTH RETARDATION 38 0.0485
108 DEVELOPMENTAL COORDINATION DISORDER 9 0.0481
109 OPHTHALMOPLEGIA 75 0.0475
110 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 234 0.0469
111 HIV TEST POSITIVE 31 0.0469
112 MICROGNATHIA 23 0.0460
113 RENAL ANEURYSM 11 0.0458
114 CLEFT LIP AND PALATE 51 0.0456
115 MECONIUM IN AMNIOTIC FLUID 16 0.0455
116 PREMATURE RUPTURE OF MEMBRANES 108 0.0448
117 PNEUMOCYSTIS CARINII PNEUMONIA 9 0.0443
118 PORTAL HYPERTENSIVE GASTROPATHY 25 0.0443
119 CRYPTORCHISM 49 0.0436
120 INFANTILE APNOEIC ATTACK 10 0.0427
121 CHORIOAMNIONITIS 8 0.0421
122 CD4 LYMPHOCYTES DECREASED 89 0.0415
123 HYPERLACTACIDAEMIA 111 0.0414
124 GENOTYPE DRUG RESISTANCE TEST POSITIVE 41 0.0399
125 BLOOD KETONE BODY INCREASED 31 0.0397
126 MACROCYTOSIS 46 0.0397
127 FAT REDISTRIBUTION 9 0.0388
128 MUSCULOSKELETAL DEFORMITY 9 0.0385
129 HAEMANGIOMA CONGENITAL 18 0.0379
130 FALLOT'S TETRALOGY 13 0.0375
131 CONGENITAL MUSCULOSKELETAL ANOMALY 16 0.0363
132 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 39 0.0360
133 PORTAL VENOUS GAS 13 0.0358
134 ULTRASOUND SCAN ABNORMAL 14 0.0357
135 ASTROCYTOMA 14 0.0354
136 COMPLICATION OF DELIVERY 10 0.0346
137 ACQUIRED GENE MUTATION 45 0.0343
138 HYPOSPADIAS 71 0.0341
139 FOETAL ARRHYTHMIA 9 0.0335
140 FOETAL DISTRESS SYNDROME 71 0.0334
141 CONGENITAL SKIN DIMPLES 8 0.0332
142 NECROTISING COLITIS 42 0.0331
143 DEATH NEONATAL 46 0.0330
144 HYPERTRIGLYCERIDAEMIA 193 0.0329
145 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 11 0.0328
146 EXTRAOCULAR MUSCLE PARESIS 15 0.0327
147 PNEUMOCYSTIS JIROVECI INFECTION 9 0.0325
148 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 22 0.0324
149 MATERNAL DRUGS AFFECTING FOETUS 247 0.0322
150 CONGENITAL HYDRONEPHROSIS 23 0.0322
151 LIPOHYPERTROPHY 20 0.0322
152 HYDROCELE 34 0.0319
153 INTRA-UTERINE DEATH 51 0.0318
154 DRUG EXPOSURE DURING PREGNANCY 1074 0.0315
155 GASTROSCHISIS 15 0.0315
156 STILLBIRTH 151 0.0312
157 SICKLE CELL ANAEMIA 20 0.0310
158 HYPERBILIRUBINAEMIA NEONATAL 18 0.0309
159 MENINGITIS CRYPTOCOCCAL 53 0.0303
160 PORTAL HYPERTENSION 92 0.0298
161 CAESAREAN SECTION 346 0.0297
162 BLOOD TRIGLYCERIDES DECREASED 10 0.0297
163 EXPOSURE DURING BREAST FEEDING 97 0.0293
164 PULMONARY HYPOPLASIA 23 0.0292
165 MESENTERIC ARTERY THROMBOSIS 11 0.0286
166 FOETAL CARDIAC DISORDER 9 0.0285
167 DRUG RESISTANCE 732 0.0285
168 ANENCEPHALY 16 0.0283
169 SICKLE CELL DISEASE 13 0.0281
170 SMALL FOR DATES BABY 139 0.0280
171 ATRIOVENTRICULAR SEPTAL DEFECT 13 0.0277
172 CONGENITAL HYDROCEPHALUS 14 0.0276
173 CENTRAL NERVOUS SYSTEM INFLAMMATION 9 0.0271
174 VOLVULUS 64 0.0270
175 MALARIA 19 0.0270
176 FOETAL EXPOSURE DURING PREGNANCY 2183 0.0268
177 NON-ALCOHOLIC FATTY LIVER 9 0.0267
178 BIOPSY LIVER ABNORMAL 8 0.0267
179 VENTRICULAR SEPTAL DEFECT 152 0.0265
180 CONGENITAL FOOT MALFORMATION 12 0.0264
181 CONGENITAL CHOROID PLEXUS CYST 8 0.0262
182 THREATENED LABOUR 11 0.0256
183 CYTOMEGALOVIRUS CHORIORETINITIS 49 0.0251
184 PATENT DUCTUS ARTERIOSUS 99 0.0249
185 SINGLE UMBILICAL ARTERY 9 0.0244
186 NEUROSIS 11 0.0243
187 PREMATURE BABY 731 0.0243
188 COARCTATION OF THE AORTA 23 0.0238
189 TWIN PREGNANCY 20 0.0238
190 AMNIOTIC CAVITY INFECTION 17 0.0235
191 SKULL MALFORMATION 15 0.0233
192 LOW BIRTH WEIGHT BABY 185 0.0233
193 CUSHING'S SYNDROME 16 0.0230
194 HEPATIC FIBROSIS 79 0.0230
195 HEPATOSPLENOMEGALY 58 0.0226
196 PNEUMATOSIS 10 0.0224
197 BRAIN MALFORMATION 8 0.0224
198 EYELID PTOSIS 227 0.0223
199 NEONATAL RESPIRATORY DISTRESS SYNDROME 79 0.0223
200 CRYPTOCOCCOSIS 36 0.0221
201 ARNOLD-CHIARI MALFORMATION 21 0.0220
202 FANCONI SYNDROME ACQUIRED 38 0.0216
203 CEREBRAL TOXOPLASMOSIS 20 0.0214
204 MULTIPLE-DRUG RESISTANCE 64 0.0206
205 LARGE FOR DATES BABY 18 0.0204
206 LIMB MALFORMATION 16 0.0203
207 INFECTIVE ANEURYSM 10 0.0202
208 LIVE BIRTH 169 0.0202
209 CYSTITIS NONINFECTIVE 27 0.0201
210 BLOOD AMYLASE INCREASED 34 0.0198
211 MENINGITIS TUBERCULOUS 11 0.0197
212 HYPOTONIA NEONATAL 30 0.0192
213 PREMATURE LABOUR 107 0.0189
214 VIRAL LOAD INCREASED 73 0.0188
215 BRONCHOPULMONARY DYSPLASIA 15 0.0186
216 MYCOBACTERIUM AVIUM COMPLEX INFECTION 49 0.0182
217 ATRIAL SEPTAL DEFECT 151 0.0180
218 SPINA BIFIDA 37 0.0177
219 CONGENITAL CYSTIC KIDNEY DISEASE 15 0.0177
220 STRABISMUS 52 0.0177
221 LYMPH NODE TUBERCULOSIS 13 0.0175
222 FEEDING DISORDER NEONATAL 18 0.0172
223 GENE MUTATION 34 0.0172
224 CLEFT LIP 15 0.0171
225 PLACENTAL DISORDER 16 0.0169
226 INDUCED LABOUR 10 0.0168
227 PLACENTA PRAEVIA 13 0.0165
228 FOETAL GROWTH RESTRICTION 99 0.0163
229 CENTRAL OBESITY 12 0.0162
230 PNEUMOCYSTIS JIROVECI PNEUMONIA 36 0.0161
231 ACUTE LYMPHOCYTIC LEUKAEMIA 45 0.0159
232 WHITE MATTER LESION 20 0.0158
233 CONGENITAL ANOMALY 122 0.0157
234 CSF PROTEIN INCREASED 13 0.0157
235 PLEOCYTOSIS 9 0.0155
236 VIRAEMIA 21 0.0152
237 DYSLIPIDAEMIA 77 0.0151
238 PULMONARY ARTERY STENOSIS CONGENITAL 11 0.0150
239 AORTIC VALVE SCLEROSIS 11 0.0150
240 HEART DISEASE CONGENITAL 53 0.0150
241 GLYCOSURIA 20 0.0148
242 CONGENITAL HAND MALFORMATION 10 0.0146
243 MICROALBUMINURIA 11 0.0146
244 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 21 0.0144
245 SYNDACTYLY 12 0.0144
246 LYMPHADENITIS 35 0.0144
247 FOETAL DISORDER 12 0.0144
248 SPEECH DISORDER DEVELOPMENTAL 41 0.0143
249 PREMATURE DELIVERY 227 0.0142
250 FANCONI SYNDROME 20 0.0141
251 NEONATAL ASPHYXIA 10 0.0141
252 BLOOD CORTISOL DECREASED 9 0.0141
253 MICROCEPHALY 18 0.0140
254 PRE-ECLAMPSIA 66 0.0139
255 SUPERINFECTION BACTERIAL 11 0.0139
256 VENTRICULAR HYPERTROPHY 33 0.0131
257 CEREBRAL VENTRICLE DILATATION 15 0.0130
258 ANHEDONIA 341 0.0130
259 FOETAL HEART RATE ABNORMAL 12 0.0130
260 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 16 0.0127
261 CEREBRAL PALSY 12 0.0126
262 HAEMANGIOMA 29 0.0125
263 HEPATOMEGALY 123 0.0125
264 ABDOMINAL SEPSIS 11 0.0125
265 PLACENTAL INSUFFICIENCY 10 0.0125
266 SYPHILIS 9 0.0124
267 HISTOPLASMOSIS 21 0.0119
268 POLYHYDRAMNIOS 12 0.0118
269 CARDIAC MURMUR 101 0.0117
270 VANISHING BILE DUCT SYNDROME 13 0.0117
271 RETINAL TOXICITY 12 0.0117
272 APGAR SCORE LOW 15 0.0116
273 VARICES OESOPHAGEAL 35 0.0116
274 RED BLOOD CELL ABNORMALITY 11 0.0114
275 HYPERTONIA 65 0.0113
276 PREGNANCY 227 0.0113
277 NEPHRITIS INTERSTITIAL 14 0.0111
278 OESOPHAGEAL VARICES HAEMORRHAGE 24 0.0110
279 OSTEOMALACIA 17 0.0110
280 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 12 0.0109
281 ILEAL ULCER 11 0.0109
282 CACHEXIA 55 0.0107
283 EXPOSURE DURING PREGNANCY 663 0.0107
284 PYLORIC STENOSIS 9 0.0106
285 HEPATITIS A 9 0.0106
286 HEART TRANSPLANT REJECTION 11 0.0106
287 OSTEOPOROTIC FRACTURE 20 0.0104
288 FAT TISSUE INCREASED 15 0.0103
289 OESOPHAGEAL CANDIDIASIS 41 0.0103
290 PORTAL VEIN THROMBOSIS 33 0.0102
291 TOXOPLASMOSIS 11 0.0102
292 NORMAL NEWBORN 55 0.0101
293 PULMONARY TUBERCULOSIS 43 0.0101
294 TALIPES 31 0.0100
295 LYMPHOCYTIC INFILTRATION 10 0.0099
296 PREMATURE SEPARATION OF PLACENTA 15 0.0097
297 GESTATIONAL DIABETES 46 0.0096
298 DEVELOPMENTAL HIP DYSPLASIA 8 0.0096
299 CLEFT PALATE 18 0.0093
300 NON-HODGKIN'S LYMPHOMA 12 0.0092
301 BLOOD TRIGLYCERIDES ABNORMAL 8 0.0091
302 DRUG EXPOSURE VIA BREAST MILK 10 0.0091
303 HYPOTONIA 91 0.0091
304 RENAL INFARCT 13 0.0090
305 OSTEOPENIA 135 0.0089
306 INSULIN RESISTANCE 18 0.0086
307 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
308 HEPATITIS B 51 0.0085
309 HYDROCEPHALUS 45 0.0083
310 CEREBELLAR SYNDROME 18 0.0082
311 DEVELOPMENTAL DELAY 74 0.0082
312 PSYCHOMOTOR RETARDATION 23 0.0082
313 LIMB DEFORMITY 13 0.0082
314 HYPERLIPIDAEMIA 97 0.0081
315 OLIGOHYDRAMNIOS 27 0.0081
316 HYPOGLYCAEMIA NEONATAL 13 0.0080
317 MENINGITIS VIRAL 11 0.0080
318 DIPLOPIA 208 0.0080
319 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 66 0.0080
320 LIP DISCOLOURATION 10 0.0079
321 FAILURE TO THRIVE 41 0.0079
322 ECONOMIC PROBLEM 119 0.0078
323 CALCULUS URINARY 12 0.0078
324 EXPOSURE VIA BREAST MILK 31 0.0078
325 LIPASE INCREASED 59 0.0077
326 PSYCHOMOTOR SKILLS IMPAIRED 20 0.0076
327 OPPORTUNISTIC INFECTION 14 0.0076
328 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8 0.0075
329 GROWTH RETARDATION 22 0.0075
330 SPLENOMEGALY 87 0.0074
331 RESPIRATORY DISORDER NEONATAL 12 0.0074
332 METABOLIC DISORDER 43 0.0074
333 JAUNDICE NEONATAL 14 0.0074
334 BLOOD BICARBONATE DECREASED 14 0.0074
335 FEBRILE CONVULSION 9 0.0074
336 OPTIC ATROPHY 12 0.0074
337 HEPATITIS TOXIC 19 0.0073
338 CONGESTIVE CARDIOMYOPATHY 30 0.0072
339 AORTIC VALVE DISEASE 11 0.0068
340 CEREBRAL ISCHAEMIA 34 0.0066
341 ASPARTATE AMINOTRANSFERASE ABNORMAL 10 0.0066
342 MYOGLOBIN BLOOD INCREASED 10 0.0065
343 PNEUMOPERITONEUM 12 0.0065
344 BLOOD UREA DECREASED 8 0.0064
345 HEPATIC NECROSIS 24 0.0064
346 JC VIRUS INFECTION 10 0.0063
347 ATROPHY 12 0.0062
348 ABORTION INDUCED 57 0.0060
349 SEBORRHOEIC DERMATITIS 10 0.0060
350 LANGUAGE DISORDER 13 0.0060
351 MATERNAL EXPOSURE DURING PREGNANCY 523 0.0059
352 ORAL CANDIDIASIS 77 0.0058
353 NYSTAGMUS 31 0.0058
354 BRONCHOPNEUMONIA 20 0.0058
355 MYCOBACTERIAL INFECTION 10 0.0058
356 GRANULOMA 20 0.0058
357 TREATMENT NONCOMPLIANCE 313 0.0057
358 ELECTROENCEPHALOGRAM ABNORMAL 18 0.0057
359 HYPERBILIRUBINAEMIA 59 0.0057
360 ATYPICAL MYCOBACTERIAL INFECTION 8 0.0057
361 TOTAL LUNG CAPACITY DECREASED 9 0.0056
362 HYPERCHOLESTEROLAEMIA 54 0.0056
363 ASPARTATE AMINOTRANSFERASE INCREASED 297 0.0056
364 LYMPHOCYTOSIS 12 0.0056
365 APRAXIA 8 0.0054
366 HEPATITIS C 65 0.0054
367 HYPERPARATHYROIDISM 11 0.0053
368 RENAL COLIC 12 0.0053
369 APLASIA PURE RED CELL 18 0.0052
370 LIVER TRANSPLANT 19 0.0052
371 BLOOD CREATINE PHOSPHOKINASE INCREASED 150 0.0052
372 FOETAL DEATH 27 0.0052
373 HEPATIC NEOPLASM MALIGNANT 11 0.0052
374 HEPATIC CYTOLYSIS 66 0.0052
375 TREATMENT FAILURE 423 0.0051
376 DYSMORPHISM 12 0.0051
377 HYDRONEPHROSIS 38 0.0051
378 UNDERWEIGHT 10 0.0051
379 DISSEMINATED TUBERCULOSIS 13 0.0051
380 ALANINE AMINOTRANSFERASE INCREASED 311 0.0051
381 GAMMA-GLUTAMYLTRANSFERASE INCREASED 112 0.0050
382 ABDOMINAL HERNIA 23 0.0050
383 BLOOD LACTATE DEHYDROGENASE INCREASED 79 0.0050
384 LACTIC ACIDOSIS 161 0.0050
385 BONE DENSITY DECREASED 154 0.0049
386 ENCEPHALITIS 34 0.0049
387 ANAEMIA 937 0.0049
388 TORSADE DE POINTES 38 0.0048
389 CYTOLYTIC HEPATITIS 16 0.0048
390 MICROCYTIC ANAEMIA 10 0.0048
391 ALANINE AMINOTRANSFERASE ABNORMAL 10 0.0047
392 END STAGE RENAL DISEASE 86 0.0047
393 HOMICIDAL IDEATION 19 0.0047
394 EXOPHTHALMOS 10 0.0046
395 CHOREA 8 0.0046
396 OSTEOPOROSIS 188 0.0046
397 DRUG TOXICITY 62 0.0045
398 PLATELET COUNT INCREASED 59 0.0045
399 AREFLEXIA 12 0.0045
400 CANDIDIASIS 18 0.0045
401 LIPIDS INCREASED 9 0.0045
402 TACHYPNOEA 60 0.0044
403 HYPERPARATHYROIDISM SECONDARY 11 0.0044
404 GASTROENTERITIS 64 0.0044
405 NEUROLOGICAL SYMPTOM 25 0.0044
406 HEPATOTOXICITY 97 0.0044
407 BLOOD TRIGLYCERIDES INCREASED 76 0.0043
408 RENAL TUBULAR DISORDER 12 0.0043
409 ECTOPIC PREGNANCY 13 0.0042
410 HEPATIC CYST 14 0.0041
411 PARADOXICAL DRUG REACTION 15 0.0041
412 DIPLEGIA 8 0.0040
413 BLOOD BILIRUBIN INCREASED 109 0.0040
414 PNEUMOCYSTIS JIROVECII PNEUMONIA 40 0.0040
415 BRONCHIOLITIS 14 0.0040
416 VITAMIN B12 DEFICIENCY 16 0.0039
417 COMMUNICATION DISORDER 15 0.0039
418 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 13 0.0039
419 ABORTION SPONTANEOUS 157 0.0039
420 PERIPHERAL VENOUS DISEASE 16 0.0039
421 FIBROSIS 12 0.0039
422 LYMPHADENOPATHY 135 0.0038
423 DILATATION VENTRICULAR 8 0.0038
424 DRUG-INDUCED LIVER INJURY 119 0.0038
425 TRICUSPID VALVE INCOMPETENCE 30 0.0038
426 HEPATIC ENCEPHALOPATHY 35 0.0037
427 CUSHINGOID 12 0.0037
428 PROTEINURIA 71 0.0037
429 RHINITIS 30 0.0037
430 HEPATITIS FULMINANT 11 0.0037
431 MYOPATHY 32 0.0037
432 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0037
433 GRANULOCYTOPENIA 21 0.0037
434 BACTERIAL SEPSIS 12 0.0037
435 NORMOCHROMIC NORMOCYTIC ANAEMIA 11 0.0037
436 HYPOPHOSPHATAEMIA 27 0.0036
437 CONJUNCTIVAL HYPERAEMIA 13 0.0036
438 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
439 INTRACRANIAL PRESSURE INCREASED 20 0.0036
440 CHEST X-RAY ABNORMAL 11 0.0036
441 BRAIN OEDEMA 45 0.0036
442 TRANSAMINASES INCREASED 79 0.0035
443 THROMBOCYTOSIS 13 0.0035
444 STEVENS-JOHNSON SYNDROME 78 0.0035
445 RESPIRATORY DISTRESS 96 0.0035
446 NEPHROPATHY TOXIC 39 0.0035
447 OCULAR ICTERUS 15 0.0035
448 BILIRUBIN CONJUGATED INCREASED 8 0.0034
449 PROTEIN TOTAL INCREASED 9 0.0034
450 BRAIN HERNIATION 10 0.0033
451 PROCEDURAL HAEMORRHAGE 13 0.0033
452 JAUNDICE 89 0.0033
453 BLOOD IMMUNOGLOBULIN E INCREASED 8 0.0033
454 BLOOD ALKALINE PHOSPHATASE INCREASED 82 0.0033
455 CHRONIC KIDNEY DISEASE 248 0.0033
456 CEREBRAL ATROPHY 13 0.0033
457 ANOREXIA 42 0.0033
458 HERPES SIMPLEX 21 0.0032
459 MULTIPLE FRACTURES 53 0.0032
460 METABOLIC ACIDOSIS 103 0.0032
461 EYE MOVEMENT DISORDER 22 0.0032
462 PROTEIN URINE PRESENT 16 0.0032
463 DRUG LEVEL INCREASED 53 0.0032
464 OSTEONECROSIS 105 0.0032
465 PYELONEPHRITIS 27 0.0031
466 EMOTIONAL DISTRESS 377 0.0031
467 CEREBRAL DISORDER 23 0.0031
468 NEPHROPATHY 29 0.0031
469 ACUTE HEPATIC FAILURE 42 0.0031
470 TUMOUR LYSIS SYNDROME 27 0.0031
471 NEUTROPENIA 416 0.0031
472 HISTIOCYTOSIS HAEMATOPHAGIC 9 0.0030
473 BONE MARROW FAILURE 61 0.0030
474 METABOLIC ENCEPHALOPATHY 9 0.0030
475 UMBILICAL HERNIA 14 0.0030
476 ATRIOVENTRICULAR BLOCK COMPLETE 20 0.0030
477 APNOEA 23 0.0030
478 BLOOD URIC ACID INCREASED 17 0.0029
479 HYPERURICAEMIA 12 0.0029
480 GLUCOSE TOLERANCE IMPAIRED 17 0.0029
481 NECROSIS 16 0.0029
482 HYPERREFLEXIA 10 0.0029
483 HEPATITIS 73 0.0029
484 MENINGITIS 19 0.0028
485 TOXIC EPIDERMAL NECROLYSIS 43 0.0028
486 HEPATIC FUNCTION ABNORMAL 105 0.0028
487 ASCITES 82 0.0028
488 NEPHROTIC SYNDROME 19 0.0028
489 CREATININE RENAL CLEARANCE DECREASED 11 0.0027
490 INTESTINAL ISCHAEMIA 15 0.0027
491 HIGH DENSITY LIPOPROTEIN DECREASED 9 0.0027
492 HYPOALBUMINAEMIA 21 0.0027
493 BLOOD IRON DECREASED 32 0.0027
494 DECREASED ACTIVITY 29 0.0027
495 CREPITATIONS 8 0.0027
496 MITRAL VALVE INCOMPETENCE 30 0.0026
497 ACIDOSIS 20 0.0026
498 CHOLESTASIS 50 0.0026
499 LYMPHOEDEMA 18 0.0026
500 BONE LOSS 39 0.0026
501 LEFT VENTRICULAR HYPERTROPHY 11 0.0026
502 VITAMIN D DEFICIENCY 25 0.0026
503 PATHOLOGICAL FRACTURE 13 0.0026
504 DISSEMINATED INTRAVASCULAR COAGULATION 36 0.0026
505 DEAFNESS UNILATERAL 14 0.0025
506 STAPHYLOCOCCAL BACTERAEMIA 11 0.0025
507 HEPATIC STEATOSIS 47 0.0025
508 RASH MACULO-PAPULAR 56 0.0025
509 PANCYTOPENIA 140 0.0025
510 HEPATIC CIRRHOSIS 47 0.0025
511 TYPE 1 DIABETES MELLITUS 15 0.0025
512 RENAL IMPAIRMENT 209 0.0025
513 SKIN TOXICITY 14 0.0025
514 FUNGAL SKIN INFECTION 10 0.0025
515 LYMPHOPENIA 35 0.0025
516 BLOOD PHOSPHORUS DECREASED 9 0.0025
517 QUALITY OF LIFE DECREASED 33 0.0025
518 GOITRE 10 0.0024
519 AMYLASE INCREASED 9 0.0024
520 HERPES VIRUS INFECTION 14 0.0024
521 BEHAVIOUR DISORDER 13 0.0024
522 NERVOUS SYSTEM DISORDER 75 0.0024
523 LOW DENSITY LIPOPROTEIN INCREASED 18 0.0023
524 HEPATITIS CHOLESTATIC 14 0.0023
525 LEUKOPENIA 116 0.0023
526 RENAL FAILURE ACUTE 98 0.0023
527 NAIL DISCOLOURATION 9 0.0023
528 MUSCLE ATROPHY 29 0.0023
529 ASPERGILLUS INFECTION 15 0.0023
530 CARDIOMEGALY 28 0.0023
531 FOOT FRACTURE 43 0.0023
532 PAPILLOEDEMA 10 0.0022
533 DRUG INTERACTION 350 0.0022
534 HAEMOLYSIS 17 0.0022
535 MULTI-ORGAN FAILURE 38 0.0022
536 POOR PERIPHERAL CIRCULATION 9 0.0021
537 CYTOMEGALOVIRUS INFECTION 35 0.0021
538 ALCOHOLISM 9 0.0021
539 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
540 BLOOD CREATININE INCREASED 136 0.0021
541 ENTEROCOLITIS 12 0.0021
542 PALLOR 56 0.0021
543 CARDIOPULMONARY FAILURE 8 0.0020
544 RENAL TUBULAR NECROSIS 20 0.0020
545 ATAXIA 24 0.0020
546 MENINGITIS ASEPTIC 9 0.0020
547 POLYNEUROPATHY 24 0.0020
548 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 15 0.0020
549 ADRENAL INSUFFICIENCY 24 0.0020
550 HAND FRACTURE 14 0.0020
551 MALNUTRITION 22 0.0020
552 ENCEPHALOPATHY 48 0.0020
553 TRANSPLANT REJECTION 15 0.0019
554 PSYCHOMOTOR HYPERACTIVITY 31 0.0019
555 REBOUND EFFECT 21 0.0019
556 STRESS FRACTURE 10 0.0019
557 CHEILITIS 10 0.0018
558 SKELETAL INJURY 19 0.0018
559 SPINAL COMPRESSION FRACTURE 15 0.0018
560 ABDOMINAL TENDERNESS 9 0.0018
561 LUNG INFILTRATION 16 0.0018
562 SUDDEN DEATH 19 0.0018
563 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
564 HEMIPARESIS 30 0.0018
565 AMMONIA INCREASED 9 0.0018
566 LABORATORY TEST ABNORMAL 52 0.0018
567 PSYCHIATRIC SYMPTOM 13 0.0018
568 FEMORAL NECK FRACTURE 9 0.0018
569 VISUAL DISTURBANCE 10 0.0017
570 GRAND MAL CONVULSION 16 0.0017
571 APLASTIC ANAEMIA 9 0.0017
572 PARTIAL SEIZURES 9 0.0017
573 SKIN LESION 47 0.0017
574 BONE DISORDER 31 0.0017
575 PHARYNGITIS 21 0.0017
576 HEPATOCELLULAR INJURY 24 0.0017
577 MYOSITIS 15 0.0017
578 INGUINAL HERNIA 10 0.0016
579 TOOTH LOSS 34 0.0016
580 BLOOD ALBUMIN DECREASED 13 0.0016
581 VENTRICULAR TACHYCARDIA 27 0.0016
582 PULMONARY HYPERTENSION 34 0.0016
583 ANURIA 14 0.0016
584 STREPTOCOCCAL INFECTION 9 0.0016
585 PANCREATITIS ACUTE 36 0.0016
586 IMMUNE SYSTEM DISORDER 21 0.0016
587 POLYURIA 13 0.0016
588 IMMUNOSUPPRESSION 14 0.0016
589 AUTOIMMUNE HEPATITIS 11 0.0016
590 RENAL FAILURE 210 0.0016
591 HAEMATOTOXICITY 15 0.0016
592 MASS 22 0.0016
593 HEPATIC FAILURE 47 0.0016
594 CARDIOMYOPATHY 23 0.0016
595 SOCIAL AVOIDANT BEHAVIOUR 9 0.0016
596 EOSINOPHILIA 27 0.0015
597 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
598 DYSARTHRIA 57 0.0015
599 STATUS EPILEPTICUS 17 0.0015
600 ERYTHEMA MULTIFORME 14 0.0015
601 ARTERIOSCLEROSIS 14 0.0015
602 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 71 0.0015
603 ACUTE RESPIRATORY DISTRESS SYNDROME 26 0.0015
604 THROMBOCYTOPENIA 164 0.0015
605 DYSPHAGIA 139 0.0015
606 AUTISM SPECTRUM DISORDER 8 0.0015
607 HAEMATURIA 49 0.0014
608 HAEMODIALYSIS 12 0.0014
609 CHOLECYSTITIS ACUTE 8 0.0014
610 ENTERITIS 9 0.0014
611 ANXIETY 397 0.0014
612 TOXIC SKIN ERUPTION 14 0.0014
613 SEPSIS 155 0.0014
614 DISEASE RECURRENCE 66 0.0014
615 OESOPHAGITIS 15 0.0014
616 ELECTROCARDIOGRAM QT PROLONGED 49 0.0014
617 PYREXIA 471 0.0014
618 LIVER DISORDER 60 0.0014
619 IMMUNODEFICIENCY 20 0.0013
620 LIVER FUNCTION TEST ABNORMAL 39 0.0013
621 HYPERKALAEMIA 47 0.0013
622 SINUS TACHYCARDIA 19 0.0013
623 ABNORMAL BEHAVIOUR 53 0.0013
624 CONVULSION 76 0.0013
625 BLOOD UREA INCREASED 22 0.0013
626 HYPERTHYROIDISM 19 0.0013
627 ACCIDENTAL OVERDOSE 48 0.0013
628 SKIN PLAQUE 11 0.0013
629 LYMPHOMA 20 0.0013
630 ACUTE MYOCARDIAL INFARCTION 38 0.0013
631 DRUG LEVEL DECREASED 13 0.0013
632 SEPTIC SHOCK 55 0.0013
633 NAIL DISORDER 11 0.0013
634 UVEITIS 17 0.0013
635 WRIST FRACTURE 15 0.0013
636 PANCREATITIS 66 0.0012
637 RHABDOMYOLYSIS 52 0.0012
638 RESPIRATORY RATE INCREASED 11 0.0012
639 NEUROPATHY PERIPHERAL 117 0.0012
640 LIVER INJURY 30 0.0012
641 RIB FRACTURE 25 0.0012
642 HYPOCALCAEMIA 23 0.0012
643 FRACTURE 23 0.0012
644 RENAL INJURY 36 0.0012
645 FEELING DRUNK 9 0.0012
646 HEMIPLEGIA 10 0.0012
647 CARDIAC FAILURE ACUTE 8 0.0012
648 HERPES ZOSTER 69 0.0012
649 HAEMOGLOBIN DECREASED 122 0.0012
650 CANDIDA INFECTION 20 0.0012
651 GASTROINTESTINAL DISORDER 106 0.0012
652 DIARRHOEA HAEMORRHAGIC 11 0.0012
653 ABNORMAL LOSS OF WEIGHT 8 0.0012
654 METRORRHAGIA 20 0.0012
655 RENAL FAILURE CHRONIC 9 0.0012
656 DYSSTASIA 34 0.0012
657 ANKLE FRACTURE 18 0.0012
658 BRONCHOPULMONARY ASPERGILLOSIS 9 0.0012
659 VENTRICULAR EXTRASYSTOLES 12 0.0012
660 COORDINATION ABNORMAL 16 0.0011
661 CHOLECYSTECTOMY 13 0.0011
662 HYPOGLYCAEMIA 55 0.0011
663 RENAL CYST 9 0.0011
664 CONJUNCTIVITIS 21 0.0011
665 ABDOMINAL DISTENSION 118 0.0011
666 OBESITY 18 0.0011
667 PERICARDIAL EFFUSION 26 0.0011
668 ACUTE KIDNEY INJURY 172 0.0011
669 DERMATITIS ALLERGIC 14 0.0011
670 NEPHROLITHIASIS 51 0.0011
671 SPEECH DISORDER 58 0.0011
672 DERMATITIS BULLOUS 8 0.0011
673 HYPOKINESIA 16 0.0011
674 NEUROTOXICITY 19 0.0011
675 HAEMATOCRIT DECREASED 21 0.0011
676 GENERAL PHYSICAL HEALTH DETERIORATION 121 0.0010
677 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
678 AFFECT LABILITY 10 0.0010
679 DIABETES MELLITUS 79 0.0010
680 ELECTROLYTE IMBALANCE 12 0.0010
681 EYELID OEDEMA 12 0.0010
682 GASTRITIS 27 0.0010
683 DRUG ERUPTION 18 0.0010
684 SKIN ULCER 26 0.0010
685 INTESTINAL PERFORATION 11 0.0010
686 HYPONATRAEMIA 55 0.0010
687 ERECTILE DYSFUNCTION 25 0.0010
688 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
689 AMENORRHOEA 17 0.0010
690 GENERALISED OEDEMA 12 0.0010
691 DEPRESSION 219 0.0010
692 RENAL DISORDER 44 0.0009
693 VASCULITIS 11 0.0009
694 HEPATIC ENZYME INCREASED 64 0.0009
695 HYPOPHAGIA 24 0.0009
696 GYNAECOMASTIA 29 0.0009
697 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 24 0.0009
698 MUSCULOSKELETAL DISCOMFORT 16 0.0009
699 NO ADVERSE EVENT 168 0.0009
700 HYPOKALAEMIA 42 0.0009
701 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
702 BLOOD SODIUM DECREASED 17 0.0009
703 MENTAL STATUS CHANGES 25 0.0009
704 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
705 GASTRIC ULCER 17 0.0009
706 CORONARY ARTERY DISEASE 27 0.0009
707 CYANOSIS 14 0.0009
708 DISTURBANCE IN ATTENTION 48 0.0009
709 CIRCULATORY COLLAPSE 15 0.0009
710 BLOOD CHOLESTEROL INCREASED 41 0.0009
711 RESPIRATORY FAILURE 64 0.0009
712 MENTAL DISORDER 38 0.0009
713 VISUAL ACUITY REDUCED 29 0.0009
714 VOMITING 407 0.0009
715 LUNG DISORDER 42 0.0009
716 HIATUS HERNIA 11 0.0008
717 MOBILITY DECREASED 61 0.0008
718 SPINAL FRACTURE 17 0.0008
719 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
720 C-REACTIVE PROTEIN INCREASED 30 0.0008
721 NO THERAPEUTIC RESPONSE 10 0.0008
722 DYSURIA 30 0.0008
723 NERVE INJURY 9 0.0008
724 PHOTOPHOBIA 15 0.0008
725 DIABETES MELLITUS INADEQUATE CONTROL 14 0.0008
726 MYOCARDITIS 9 0.0008
727 FEBRILE NEUTROPENIA 52 0.0008
728 COAGULOPATHY 13 0.0008
729 FACE OEDEMA 13 0.0008
730 PARALYSIS 11 0.0008
731 EYE DISORDER 25 0.0008
732 STAPHYLOCOCCAL INFECTION 25 0.0008
733 CHROMATURIA 17 0.0008
734 ABSCESS 12 0.0008
735 HAEMATEMESIS 19 0.0007
736 IMPAIRED WORK ABILITY 16 0.0007
737 GASTROOESOPHAGEAL REFLUX DISEASE 60 0.0007
738 SCHIZOPHRENIA 9 0.0007
739 HYPOXIA 26 0.0007
740 RESPIRATORY DISORDER 22 0.0007
741 ASPIRATION 8 0.0007
742 MYALGIA 124 0.0007
743 CYST 9 0.0007
744 ABNORMAL DREAMS 20 0.0007
745 INTENTIONAL PRODUCT USE ISSUE 63 0.0007
746 HIP ARTHROPLASTY 11 0.0007
747 NIGHT SWEATS 23 0.0007
748 DYSKINESIA 29 0.0007
749 HYPERTENSION 151 0.0007
750 FEMUR FRACTURE 22 0.0007
751 PAIN 427 0.0007
752 PNEUMOTHORAX 11 0.0007
753 MUCOSAL INFLAMMATION 18 0.0007
754 HYPERGLYCAEMIA 25 0.0007
755 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
756 BLOOD POTASSIUM INCREASED 11 0.0007
757 TACHYCARDIA 60 0.0007
758 BACTERAEMIA 8 0.0007
759 GAIT DISTURBANCE 129 0.0007
760 THIRST 12 0.0007
761 RED BLOOD CELL COUNT DECREASED 19 0.0007
762 OEDEMA 36 0.0007
763 NEOPLASM PROGRESSION 23 0.0007
764 WEIGHT DECREASED 183 0.0007
765 DRUG DISPENSING ERROR 10 0.0007
766 SHOCK 15 0.0007
767 DEAFNESS 17 0.0006
768 ABDOMINAL PAIN 151 0.0006
769 PULMONARY EMBOLISM 61 0.0006
770 MYELOSUPPRESSION 23 0.0006
771 MUSCULOSKELETAL DISORDER 12 0.0006
772 APHASIA 19 0.0006
773 RESTLESSNESS 23 0.0006
774 HYPOTHYROIDISM 20 0.0006
775 DRUG ABUSE 52 0.0006
776 THERAPY NON-RESPONDER 28 0.0006
777 EPILEPSY 19 0.0006
778 RASH GENERALISED 16 0.0006
779 BLINDNESS 25 0.0006
780 OSTEOARTHRITIS 26 0.0006
781 AGITATION 45 0.0006
782 EATING DISORDER 13 0.0006
783 DIARRHOEA 387 0.0006
784 MEDICATION ERROR 33 0.0006
785 ANGINA PECTORIS 17 0.0006
786 DEHYDRATION 79 0.0006
787 AGRANULOCYTOSIS 11 0.0006
788 LETHARGY 34 0.0006
789 BACTERIAL INFECTION 11 0.0006
790 NIGHTMARE 20 0.0006
791 CEREBRAL INFARCTION 14 0.0006
792 DEEP VEIN THROMBOSIS 37 0.0006
793 DRUG INTOLERANCE 55 0.0006
794 TOXICITY TO VARIOUS AGENTS 96 0.0006
795 BLINDNESS UNILATERAL 8 0.0006
796 SLEEP DISORDER 40 0.0006
797 HEAD DISCOMFORT 10 0.0006
798 TYPE 2 DIABETES MELLITUS 19 0.0006
799 CARDIOGENIC SHOCK 8 0.0006
800 COGNITIVE DISORDER 26 0.0006
801 DISORIENTATION 22 0.0006
802 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
803 UPPER LIMB FRACTURE 11 0.0006
804 BRADYCARDIA 29 0.0005
805 HAEMATOCHEZIA 30 0.0005
806 DRUG WITHDRAWAL SYNDROME NEONATAL 8 0.0005
807 COMA 25 0.0005
808 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
809 INTERSTITIAL LUNG DISEASE 25 0.0005
810 SEIZURE 59 0.0005
811 ASTHENIA 191 0.0005
812 URINARY INCONTINENCE 15 0.0005
813 INTESTINAL OBSTRUCTION 19 0.0005
814 POLLAKIURIA 21 0.0005
815 CEREBRAL HAEMORRHAGE 18 0.0005
816 OEDEMA PERIPHERAL 61 0.0005
817 BLOOD POTASSIUM DECREASED 15 0.0005
818 CARDIAC FAILURE 40 0.0005
819 PLATELET COUNT DECREASED 53 0.0005
820 DECREASED APPETITE 115 0.0005
821 BONE PAIN 29 0.0005
822 RASH PAPULAR 11 0.0005
823 ABASIA 12 0.0005
824 DEATH 418 0.0005
825 PERITONITIS 10 0.0005
826 CARDIOVASCULAR DISORDER 12 0.0005
827 MYOCARDIAL INFARCTION 82 0.0005
828 LOWER LIMB FRACTURE 9 0.0005
829 ACUTE RESPIRATORY FAILURE 9 0.0005
830 GLAUCOMA 9 0.0005
831 HAEMOPTYSIS 13 0.0005
832 IRRITABILITY 28 0.0005
833 PRESCRIBED OVERDOSE 9 0.0005
834 WHITE BLOOD CELL COUNT DECREASED 50 0.0005
835 DELIRIUM 16 0.0005
836 PLEURAL EFFUSION 28 0.0005
837 CARDIO-RESPIRATORY ARREST 19 0.0005
838 MELAENA 10 0.0005
839 DYSPNOEA EXERTIONAL 17 0.0005
840 SKIN DISORDER 15 0.0004
841 CONDITION AGGRAVATED 135 0.0004
842 PNEUMONIA 143 0.0004
843 FLATULENCE 25 0.0004
844 PNEUMONIA ASPIRATION 11 0.0004
845 PSYCHOTIC DISORDER 13 0.0004
846 HIP FRACTURE 14 0.0004
847 INFECTION 63 0.0004
848 THROMBOSIS 35 0.0004
849 CONFUSIONAL STATE 70 0.0004
850 MOUTH ULCERATION 9 0.0004
851 INFLAMMATION 22 0.0004
852 RASH 185 0.0004
853 RESPIRATORY TRACT INFECTION 11 0.0004
854 FUNGAL INFECTION 14 0.0004
855 DIABETIC KETOACIDOSIS 10 0.0004
856 ILL-DEFINED DISORDER 25 0.0004
857 EXTRAPYRAMIDAL DISORDER 10 0.0004
858 AMNESIA 26 0.0004
859 COUGH 112 0.0004
860 PRODUCTIVE COUGH 19 0.0004
861 ABDOMINAL PAIN LOWER 10 0.0004
862 BODY TEMPERATURE INCREASED 8 0.0004
863 VAGINAL HAEMORRHAGE 17 0.0004
864 CARDIAC ARREST 32 0.0004
865 MUSCULAR WEAKNESS 44 0.0004
866 NAUSEA 296 0.0004
867 TREMOR 62 0.0004
868 SUICIDAL IDEATION 34 0.0004
869 MENTAL IMPAIRMENT 9 0.0004
870 SKIN DISCOLOURATION 17 0.0004
871 COLITIS 14 0.0004
872 NEUTROPHIL COUNT DECREASED 15 0.0004
873 CHOLELITHIASIS 12 0.0004
874 DISEASE PROGRESSION 43 0.0004
875 HYPOTENSION 72 0.0004
876 DRUG ADMINISTRATION ERROR 11 0.0004
877 BACK PAIN 83 0.0004
878 RECTAL HAEMORRHAGE 15 0.0003
879 RASH MACULAR 12 0.0003
880 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
881 CARDIAC FAILURE CONGESTIVE 27 0.0003
882 GASTROINTESTINAL HAEMORRHAGE 28 0.0003
883 OVERDOSE 72 0.0003
884 RASH PRURITIC 18 0.0003
885 HEADACHE 208 0.0003
886 CRYING 12 0.0003
887 HYPERSENSITIVITY 60 0.0003
888 DEPRESSED MOOD 17 0.0003
889 ERYTHEMA 66 0.0003
890 GASTRIC DISORDER 11 0.0003
891 AGGRESSION 16 0.0003
892 SOMNOLENCE 64 0.0003
893 RASH ERYTHEMATOUS 15 0.0003
894 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
895 ADVERSE EVENT 28 0.0003
896 OXYGEN SATURATION DECREASED 17 0.0003
897 HYPOAESTHESIA 45 0.0003
898 FATIGUE 234 0.0003
899 INSOMNIA 79 0.0003
900 DISCOMFORT 18 0.0003
901 PULMONARY OEDEMA 13 0.0003
902 DRUG INEFFECTIVE 380 0.0003
903 BLOOD PRESSURE DECREASED 19 0.0003
904 CHILLS 33 0.0003
905 URINARY TRACT INFECTION 48 0.0003
906 VERTIGO 17 0.0003
907 HYPOACUSIS 12 0.0003
908 MALAISE 121 0.0003
909 OCULAR HYPERAEMIA 13 0.0003
910 PALPITATIONS 32 0.0003
911 ARTHROPATHY 15 0.0003
912 MUSCULOSKELETAL PAIN 14 0.0003
913 WEIGHT INCREASED 58 0.0003
914 DYSPNOEA 144 0.0003
915 ARTHRITIS 20 0.0003
916 ECZEMA 13 0.0002
917 ROAD TRAFFIC ACCIDENT 10 0.0002
918 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
919 CHEST PAIN 44 0.0002
920 STOMATITIS 14 0.0002
921 DIZZINESS 115 0.0002
922 BRONCHITIS 17 0.0002
923 LOSS OF CONSCIOUSNESS 29 0.0002
924 CARDIAC DISORDER 21 0.0002
925 COLITIS ULCERATIVE 10 0.0002
926 DYSPEPSIA 21 0.0002
927 CEREBROVASCULAR ACCIDENT 36 0.0002
928 ARTHRALGIA 88 0.0002
929 VISION BLURRED 29 0.0002
930 ARRHYTHMIA 10 0.0002
931 MEMORY IMPAIRMENT 28 0.0002
932 HYPERHIDROSIS 26 0.0002
933 CATARACT 12 0.0002
934 HAEMORRHAGE 21 0.0002
935 SUICIDE ATTEMPT 12 0.0002
936 TINNITUS 9 0.0002
937 BLISTER 11 0.0002
938 OFF LABEL USE 169 0.0002
939 HEART RATE INCREASED 19 0.0002
940 DYSPHONIA 11 0.0002
941 BLOOD GLUCOSE DECREASED 9 0.0002
942 PAIN IN EXTREMITY 55 0.0002
943 DRUG EFFECT DECREASED 10 0.0002
944 BALANCE DISORDER 16 0.0002
945 DRUG WITHDRAWAL SYNDROME 16 0.0002
946 THERAPEUTIC RESPONSE DECREASED 11 0.0002
947 SYNCOPE 18 0.0002
948 NEOPLASM MALIGNANT 12 0.0002
949 ABDOMINAL PAIN UPPER 37 0.0002
950 NECK PAIN 10 0.0002
951 CELLULITIS 9 0.0002
952 PARAESTHESIA 27 0.0002
953 VISUAL IMPAIRMENT 21 0.0002
954 SWELLING FACE 11 0.0002
955 ADVERSE DRUG REACTION 15 0.0002
956 CHEST DISCOMFORT 17 0.0002
957 CONSTIPATION 35 0.0002
958 EPISTAXIS 12 0.0002
959 DRY EYE 8 0.0002
960 PRODUCT USE ISSUE 30 0.0002
961 HALLUCINATION 12 0.0002
962 UNEVALUABLE EVENT 12 0.0002
963 DRY MOUTH 12 0.0001
964 ABDOMINAL DISCOMFORT 24 0.0001
965 ALOPECIA 28 0.0001
966 MUSCLE SPASMS 26 0.0001
967 ASTHMA 15 0.0001
968 SKIN EXFOLIATION 11 0.0001
969 SINUSITIS 13 0.0001
970 PRODUCT USE IN UNAPPROVED INDICATION 31 0.0001
971 PRURITUS 47 0.0001
972 DYSGEUSIA 8 0.0001
973 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
974 BLOOD GLUCOSE INCREASED 20 0.0001
975 INTENTIONAL PRODUCT MISUSE 9 0.0001
976 MUSCULOSKELETAL STIFFNESS 9 0.0001
977 ATRIAL FIBRILLATION 10 0.0001
978 BLOOD PRESSURE INCREASED 15 0.0001
979 HOSPITALISATION 15 0.0001
980 INCORRECT DOSE ADMINISTERED 22 0.0001
981 FALL 32 0.0001
982 COMPLETED SUICIDE 8 0.0001
983 URTICARIA 15 0.0001
984 COVID-19 14 0.0001
985 PSORIASIS 10 0.0001
986 NASOPHARYNGITIS 13 0.0001
987 PERIPHERAL SWELLING 10 0.0001
988 FEELING ABNORMAL 14 0.0001
989 DRUG DOSE OMISSION 8 0.0000